Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Stickney Hill Dairy, LLC

Stickney Hill Dairy, LLC Recalls

All product recalls associated with Stickney Hill Dairy, LLC.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

304

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 141–160 of 4747 recalls

Boar's Head Goat Cheese (Stickney Hill) – Incorrect Date (2025)

Package has incorrect Use By date.

Class IIILow

FDAJul 23, 2025NY• Stickney Hill Dairy, LLC

Lorazepam Injection (Hikma) – Compound Impurities (2025)

Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds

Class IIModerate

FDAJul 22, 2025Nationwide• Hikma Pharmaceuticals USA Inc.

STA-Fibrinogen 5 (Diagnostica Stago) – Contamination Risk (2025)

Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.

FDA

1...6 789 10...238

Page 8 of 238Next

Jul 21, 2025

Nationwide

• Diagnostica Stago, Inc.

STA-Liquid Anti-Xa 8 (Diagnostica Stago) – Contamination Risk (2025)

Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.

FDAJul 21, 2025Nationwide• Diagnostica Stago, Inc.

STA-Liquid Anti-Xa 4 (Diagnostica Stago) – Contamination Risk (2025)

Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.

FDAJul 21, 2025Nationwide• Diagnostica Stago, Inc.

STA Satellite (Diagnostica Stago) – Contamination Risk (2025)

Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.

FDAJul 21, 2025Nationwide• Diagnostica Stago, Inc.

Duloxetine Capsules (Breckenridge Pharmaceutical) – Impurity Concern (2025)

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above safety assessment limit

Class IIModerate

FDAJul 15, 2025Nationwide• Breckenridge Pharmaceutical, Inc.

VITROS Chemistry Ca Slides (Ortho-Clinical) – Calibration Error (2025)

Generations 67 and above of VITROS Ca Slides are experiencing an increased occurrence of Condition Code TH4-63J during calibration on VITROS XT 3400 and VITROS XT 7600 Systems, causing calibration failures that delay calcium test results and potentially impact patient management. The imaging reflectometer algorithm detects excessive "spikes" (imperfections) in slide images and generates the TH4-63J condition code when the threshold of 600 spikes is exceeded. Updated analysis revealed a 19-fold increase in failure rates from 0.0043% (2024 baseline) to 0.082% for Generation 67+ slides in 2025, with 100% of calibrator failures occurring at the lowest concentration level. This can result in delayed diagnosis and treatment of conditions such as hypercalcemic crisis, parathyroid disorders, and other calcium-related emergencies requiring urgent intervention.

FDAJul 9, 2025Nationwide• Ortho-Clinical Diagnostics, Inc.

epoc BGEM BUN Test Card (Siemens) – Sodium Bias (2025)

Siemens Healthcare Diagnostics Inc. has confirmed that a negative sodium bias may exist in some epoc test card lots. All other analytes are performing as intended. The observed average bias for sodium was -4.4 mmol/L. The maximum bias observed was -14 mmol/L, which occurred at a higher sodium concentration around 150 mmol/L. No positive bias has been observed. Quality Control (QC) fluid may or may not detect the issue depending on the bias magnitude and the frequency of QC testing.

FDAJul 7, 2025Nationwide• Siemens Healthcare Diagnostics Inc

Orascoptic Superior Visualization (Orascoptic) – Nickel Allergy Risk (2025)

Due to complaints, loupe nose pads containing nickel may cause an allergic reaction.

FDAJul 3, 2025Nationwide• Orascoptic Surgical Acuity

Amlodipine Benazepril Capsules (Lupin) – Incorrect Expiration (2025)

Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027

Class IIModerate

FDAJul 2, 2025Nationwide• Lupin Pharmaceuticals Inc.

Pro Spotter (TICO) – Non-DOT Brake Fitting (2025)

Terminal Investment Corporation (TICO) is recalling certain 2024-2025 Pro Spotter trucks. The vehicles may be equipped with a non-DOT brake line fitting, resulting in reduced braking performance. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard number 121, "Air Brake Systems."

NHTSAJun 30, 2025Nationwide• TICO

Duloxetine Capsules (Breckenridge) – CGMP Impurity (2025)

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Class IIModerate

FDAJun 30, 2025Nationwide• Breckenridge Pharmaceutical, Inc.

ClomiPRAMINE Hydrochloride Capsules (Lupin) – Impurity Specification Failure (2025)

Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.

Class IIModerate

FDAJun 27, 2025Nationwide• Lupin Pharmaceuticals Inc.

RAPIDPoint 500 Wash Cartridge (Siemens) – Manufacturing Error (2025)

Siemens Healthcare Diagnostics is recalling the RAPIDPoint 500 Systems Wash/Waste Cartridge Lot WW/08925 due to a manufacturing error causing positive and negative bias in Ionized Calcium, Potassium, pH, Chloride, pCO2, Glucose and Lactate analytes and their derivatives. Four complaints were filed related to this event that led to Siemens Healthcare Diagnostics identifying an error in the manufacturing process and initiated corrective actions. Use of the affected device may result in errors during QC which could lead to a delay in patient treatment. If bias generated from this issue is not caught during QC erroneous results may cause temporary or medically reversible adverse health consequences to patients.

FDAJun 26, 2025Nationwide• Siemens Healthcare Diagnostics Inc

Metoprolol Succinate Tablets 25mg (Granules) – Dissolution Specification Failure (2025)

Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term.

Class IIModerate

FDAJun 24, 2025Nationwide• Granules Pharmaceuticals Inc.

Lisinopril/Hydrochlorothiazide Tablets (Lupin) – Product Mix-Up (2025)

Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.

Class IIModerate

FDAJun 20, 2025Nationwide• Lupin Pharmaceuticals Inc.

Lisdexamfetamine Capsules 60mg (Sun Pharma) – Dissolution Failure (2025)

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).

Class IIModerate

FDAJun 16, 2025Nationwide• SUN PHARMACEUTICAL INDUSTRIES INC

VITROS Chemistry OP Reagent (Ortho-Clinical) – QC Result Concern (2025)

Lots from Generation (GEN) 15 of VITROS Chemistry Products OP Reagent may generate lower than expected quality control (QC) results. If the customer is unable to get passing quality control results, then the customer would be unable to run the OP-LO protocol leading to a potential delay in patient results.

FDAJun 12, 2025Nationwide• Ortho-Clinical Diagnostics, Inc.

Famciclovir Tablets 500mg (Macleods) – Foreign Substance Found (2025)

Presence of Foreign Substance- Black hair strand found attached to a tablet in a sealed bottle.

Class IIILow

FDAJun 11, 2025Nationwide• Macleods Pharmaceuticals Ltd